Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a 20-minute music session retrain the ADHD brain?

NCT ID NCT07793045

Symptom relief Sponsor: California State University, San Bernardino Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 28, 2026 · Last updated Sep 02, 2026 · Updated 2 times

Summary

This trial tests whether listening to music with embedded binaural beats can improve attention and memory in adults with ADHD. Forty adults will be randomly assigned to either a binaural beats group or a control group, both attending 12 supervised listening sessions over six weeks. Only the intervention group's music contains the binaural beats. Researchers will measure changes in attention and memory before and after the program, and also track attendance and enjoyment to see if the approach is practical and acceptable.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Music-based binaural beats stimulation
What this could lead to
If it works, this could offer a drug-free, home-friendly way to help adults with ADHD sharpen attention and memory.
What could go wrong
This is a small early-stage trial focused on feasibility, so it may not show clear cognitive benefits. Results may not apply to all people with ADHD, and listening to binaural beats may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 55 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adults aged 18 to 55 years 2. Previous diagnosis of attention-deficit/hyperactivity disorder (ADHD) made by a qualified healthcare professional and supported by the Adult ADHD Self-Report Scale, version 1.1 (ASRS-v1.1) 3. Willing to wear headphones during the listening sessions 4. Able and willing to attend 12 listening sessions conducted twice weekly over six weeks - Exclusion Criteria: 1. Anticipated absence from the study area for more than seven days during the two-month study period 2. Uncorrectable hearing impairment that would prevent adequate delivery of music through headphones 3. Acute psychiatric condition, such as depression 4. Intellectual or developmental disability that could interfere with study participation 5. Acute medical condition resulting in sensory impairment 6. Initiation of, or a change in dosage of, stimulant, antipsychotic, or analgesic medication within the previous month 7. Anticipated change in stimulant, antipsychotic, or analgesic medication during the study period

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Attention deficit/hyperactivity disorder (ADHD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Attention deficit/hyperactivity disorder (ADHD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • California State University, San Bernardino

    RECRUITING

    San Bernardino, California, 92407, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.